Tag: Cannabis

Easier access to medicinal cannabis and soaring sales in Germany, Key Insights by Adam Isaac Miller | Jun 28/2020

Reading Time: 2 minutes Regulations changes – This week the QLD government removed the state approval process required for patients to access medical cannabis. Now doctors will only require Federal approval from the TGA, this should lead to an increase in prescriptions across the State. On the other side of the world, the Swiss government wants […]

Psychedelics for Mental Health and a Glimpse into the European Cannabis Market, Key Insights by Adam Isaac Miller | Jun 21/2020

Reading Time: 3 minutes The importance of standardization – Authorities across Europe have listed 114 products containing CBD in the European Union’s food-safety alert system since the start of last year, with data indicating that some countries are policing novel-food violations more frequently than others. This is an excellent example of the importance of harmonization […]

Canadian Medicinal Cannabis Exports and the Future of Psychedelics, Key Insights by Adam Isaac Miller | Jun 14/2020

Reading Time: 2 minutes Export of cannabis – Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production later this year. In 2019, federally regulated producers in Canada exported roughly 3,740 kilograms (8,245 pounds) […]

THC Found to Treat Pain and More, Key Insights by Adam Isaac Miller | Jun 07/2020

Reading Time: 2 minutes Cannabis vaporization and pain – A study led by a team of Israeli scientists, published earlier recently in the European Journal of Pain, found precise doses of THC administered via inhaler were effective in reducing pain in neuropathy patients. The randomized placebo-controlled study divided 27 chronic pain patients into three groups: […]

Cannabis Farming Accounts For $2.3b In Cash Receipts and the Benefits of Cannabis on Memory Abilities, Key Insights by Adam Isaac Miller | May 31/2020

Reading Time: 3 minutes The wonders of psychedelic compounds – A beautiful excerpt from Franz X. Vollenweider, recent years have seen a burgeoning scientific interest in the neurobiology of altered states of consciousness induced by psychedelic drugs (e.g. such as psilocybin, LSD, and DMT), also driven by renewed and growing evidence of their beneficial clinical effects […]

MDMA a Therapeutic Life-Saver for US Veterans in Recent Trial, Key Insights by Adam Isaac Miller | May 24/2020

Reading Time: 2 minutes MDMA for PTSD – MDMA, the active ingredient in the party drug ecstasy, is being touted as a game-changing treatment for post-traumatic stress disorder. It is being trialed in America—and for one army veteran the drug has been a life-saver – this is a truly marvelous video  EU is a cast cannabis landscape – The […]

Important Updates From Cannabis in Germany and US Federal Legal Action – Adam Isaac Miller’s update | May 03/2020

Reading Time: 2 minutes Cannabis in Germany – A great article by my good friend Alfredo Pascual (Link) – Germany imported 1,032 kilograms (2,275 pounds) of medical cannabis flower for pharmacy dispensing through March 6, an amount that indicates little if any growth versus the average cannabis imported in 2019 over an equivalent amount of time. […]

The wonders of the cannabis Sativa plant and possible reclassification of CBD – Adam Isaac Miller’s update | Apr 26/2020

Reading Time: 2 minutes The marvel of the cannabis plant is endless – here is an excerpt I came across this week speaking about the cannabis Sativa plant. The plant is a wonder of nature, a factory for brain-altering chemicals unlike any the world has ever seen. But there is a tremendous amount of variance […]

Cannabis Corner, Key Insights by Adam Isaac Miller | Apr 13/2020

Reading Time: 2 minutes A note on psychedelics – Before they were banned about a half-century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. Researchers say it’s time for regulators, scientists, and the public to ‘revisit drugs that were once used but fell out of […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 16/2020

Reading Time: 2 minutes Europe offers growth opportunities for the next wave of cannabis organisations. The UK, Germany, Italy and the Netherlands already have legal systems in place for medicinal cannabis and France and Spain are currently reviewing key legislative reform to align themselves with international practices. In addition to medicinal cannabis, several key […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 09/2020

Reading Time: 2 minutes Brazil and New Zealand share common fates as the two countries open up patients’ ability to access medical cannabis. Both countries emphasise GMP only products, meaning companies that intend to import into these countries require manufacture under EUGMP (or equivalent). This is however ambiguous, as the manufacturing process of cannabis […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Jan 12/2020

Reading Time: 2 minutes 3,682 medicinal cannabis prescriptions were approved via SAS Category B in December 2019. Prescriptions throughout 2019, increased month on month excluding November which dropped by 190 prescriptions compared to October. The only drop in prescriptions recorded before this was in December 2018 when prescriptions were lower than November numbers. As […]